Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFCILLIN vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFCILLIN vs NALMEFENE: Safety Overview

Metric NAFCILLIN NALMEFENE
Total FAERS Reports 215 197
Deaths Reported 18 77
Death Rate 8.4% 39.1%
Hospitalizations 98 118
Average Patient Age 50.7 yrs 44.2 yrs
% Female Patients 50.5% 39.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 17, 1995
Manufacturer Eugia US LLC Purdue Pharma L.P.
Route INTRAVENOUS INTRAMUSCULAR
Marketing Status Discontinued Discontinued